ID

24889

Descripción

Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00571285

Link

https://clinicaltrials.gov/show/NCT00571285

Palabras clave

Versiones (1)
  1. 22/8/17 22/8/17 -
Subido en

22 de agosto de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Parkinson's Disease NCT00571285

Inglés

Eligibility Parkinson's Disease NCT00571285

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
eligible participants must be able to provide informed consent or have a legal representative (defined by georgia law) who can give consent.
Descripción

Informed Consent | Informed Consent Patient Representative

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C0030701
diagnosis of ipd, based on history of 2/3 cardinal features of pd (tremor, bradykinesia and rigidity) and definite response to dopaminergic therapy.
Descripción

Parkinson Disease | Tremor | Bradykinesia | Rigidity | Dopamine Agonists Good therapeutic response

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0030567
UMLS CUI [2]
C0040822
UMLS CUI [3]
C0233565
UMLS CUI [4]
C0026837
UMLS CUI [5,1]
C0178601
UMLS CUI [5,2]
C0184785
previous serum 25-oh vitamin d concentration measured by treating physician within previous 3 months.
Descripción

25-Oh D Vitamin Test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1255280
eligible participants must be able to complete the study questionnaires and assessments (e.g., participant must be judged able to complete tug at screening/baseline).
Descripción

Clinical Trial Subject Questionnaire Completion | TUG Completion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3890411
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C1319201
UMLS CUI [2,2]
C0205197
participants must be free of active cancer or other serious medical condition which might reasonably preclude their completing the 6-month intervention.
Descripción

Malignant Neoplasm Free of | Medical condition Serious Free of

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332296
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0332296
participants must be able to complete an 8 meter walk at screening evaluation.
Descripción

Able to walk Meter Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2712089
UMLS CUI [1,2]
C0475209
UMLS CUI [1,3]
C1265611
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with pd, h&y stage i-iv will be eligible to participate in this study.
Descripción

Parkinson Disease Hoehn and Yahr grades

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C0451215
participants must be ages 18-89 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
patient with a history of hypercalcemia, hypercalciuria, liver failure, end-stage renal disease (national kidney foundation classification stage 5) or kidney stones within the past 5 years will be excluded.
Descripción

Hypercalcemia | Hypercalciuria | Liver Failure | Chronic Kidney Failure Chronic kidney disease NKF classification | Kidney Calculi

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020437
UMLS CUI [2]
C0020438
UMLS CUI [3]
C0085605
UMLS CUI [4,1]
C0022661
UMLS CUI [4,2]
C2074730
UMLS CUI [5]
C0022650
specifically, potential participants with gfr (estimated or measured) <15 ml/min are excluded.
Descripción

Estimated Glomerular Filtration Rate | Glomerular Filtration Rate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3811844
UMLS CUI [2]
C0017654
Volver a la parte superior de la página

Similar models

Eligibility Parkinson's Disease NCT00571285

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent | Informed Consent Patient Representative
Item
eligible participants must be able to provide informed consent or have a legal representative (defined by georgia law) who can give consent.
boolean
C0021430 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C0030701 (UMLS CUI [2,2])
Parkinson Disease | Tremor | Bradykinesia | Rigidity | Dopamine Agonists Good therapeutic response
Item
diagnosis of ipd, based on history of 2/3 cardinal features of pd (tremor, bradykinesia and rigidity) and definite response to dopaminergic therapy.
boolean
C0030567 (UMLS CUI [1])
C0040822 (UMLS CUI [2])
C0233565 (UMLS CUI [3])
C0026837 (UMLS CUI [4])
C0178601 (UMLS CUI [5,1])
C0184785 (UMLS CUI [5,2])
25-Oh D Vitamin Test
Item
previous serum 25-oh vitamin d concentration measured by treating physician within previous 3 months.
boolean
C1255280 (UMLS CUI [1])
Clinical Trial Subject Questionnaire Completion | TUG Completion
Item
eligible participants must be able to complete the study questionnaires and assessments (e.g., participant must be judged able to complete tug at screening/baseline).
boolean
C3890411 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C1319201 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Malignant Neoplasm Free of | Medical condition Serious Free of
Item
participants must be free of active cancer or other serious medical condition which might reasonably preclude their completing the 6-month intervention.
boolean
C0006826 (UMLS CUI [1,1])
C0332296 (UMLS CUI [1,2])
C3843040 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0332296 (UMLS CUI [2,3])
Able to walk Meter Quantity
Item
participants must be able to complete an 8 meter walk at screening evaluation.
boolean
C2712089 (UMLS CUI [1,1])
C0475209 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Parkinson Disease Hoehn and Yahr grades
Item
patients with pd, h&y stage i-iv will be eligible to participate in this study.
boolean
C0030567 (UMLS CUI [1,1])
C0451215 (UMLS CUI [1,2])
Age
Item
participants must be ages 18-89 years.
boolean
C0001779 (UMLS CUI [1])
Hypercalcemia | Hypercalciuria | Liver Failure | Chronic Kidney Failure Chronic kidney disease NKF classification | Kidney Calculi
Item
patient with a history of hypercalcemia, hypercalciuria, liver failure, end-stage renal disease (national kidney foundation classification stage 5) or kidney stones within the past 5 years will be excluded.
boolean
C0020437 (UMLS CUI [1])
C0020438 (UMLS CUI [2])
C0085605 (UMLS CUI [3])
C0022661 (UMLS CUI [4,1])
C2074730 (UMLS CUI [4,2])
C0022650 (UMLS CUI [5])
Estimated Glomerular Filtration Rate | Glomerular Filtration Rate
Item
specifically, potential participants with gfr (estimated or measured) <15 ml/min are excluded.
boolean
C3811844 (UMLS CUI [1])
C0017654 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial